GlassScriptPhysician profile
Cynthia Frey
NPI 1659501625
$1,513.41
in general payments reported to CMS, 2019-2025
19 companies · $481 in 2025
The $481 reported for 2025 was more than what 76% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $190 · 2022: $212 · 2023: $527 · 2024: $103 · 2025: $481.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,112.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,111.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $420.31 | 2021-2025 | Ensite Precision, Cardiomems |
| Pfizer INC. | $157.94 | 2023-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $123.51 | 2023-2025 | Jardiance |
| Boston Scientific Corporation | $111.95 | 2022-2023 | Watchman Access System |
| Merck Sharp & Dohme LLC | $106.08 | 2022-2025 | Verquvo |
| Novartis Pharmaceuticals Corporation | $83.47 | 2023-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $78.29 | 2022-2023 | |
| Janssen Pharmaceuticals, INC | $69.39 | 2022-2023 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $69.04 | 2025 | Wainua |
| Philips North America LLC | $52.23 | 2024-2025 | Ambulatory Monitoring & Diagnostics Undivided, (Ck4) Mcot, (Ck7) Extended Holter |
| Novo Nordisk INC | $49.30 | 2023 | Ozempic |
| Amgen INC. | $46.48 | 2022-2025 | Repatha, Repatha |
| Abiomed | $30.49 | 2024 | Impella |
| Irhythm Technologies, INC. | $27.09 | 2024 | Zio Monitor, Zio Xt Patch |
| Angiodynamics, INC. | $21.61 | 2023 | Auryon Laser System 100-120 Vac |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lemaitre Vascular, INC. | $19.91 | 2023 | Artegraft Vascular Graft |
| Bridgebio Pharma, INC. | $15.81 | 2025 | Attruby |
| Actelion Pharmaceuticals US, INC. | $15.27 | 2023 | Opsumit, Uptravi |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $15.24 | 2023 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cynthia Frey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.